Format

Send to

Choose Destination
Surg Pathol Clin. 2019 Sep;12(3):651-669. doi: 10.1016/j.path.2019.03.010. Epub 2019 May 23.

Defining the Boundary Between Myelodysplastic Syndromes and Myeloproliferative Neoplasms.

Author information

1
Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
2
Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. Electronic address: swang5@mdanderson.org.

Abstract

In this article we provide a practical and comprehensive review of myeloid neoplasms with overlapping myelodysplastic (MDS) and myeloproliferative (MPN) features, with emphasis on recent updates in classification, particularly the utility of morphologic, cytogenetic, and molecular findings in better defining and classifying these disease entities. We provide the reader with a summary of the most recent developments and updates that have helped further our understanding of the genomic landscape, clinicopathologic features, and prognostic elements of myeloid neoplasms with MDS/MPN features.

KEYWORDS:

Atypical CML; CMML; Cytopenia; Cytosis; MDS; MDS/MPN; MPN; Ring sideroblasts

PMID:
31352979
DOI:
10.1016/j.path.2019.03.010

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center